FDA Intensifies Drug Enforcement and Seizures in Punjab

Since January 1, 2025, the Food and Drug Administration has intensified enforcement actions in Punjab, conducting 1,620 inspections and making 32 seizures in the Amritsar zone. These raids led to the seizure of drugs valued at Rs 1.15 crore, including 3.75 lakh capsules and tablets, primarily containing tramadol and pregabalin. The regulatory action included suspending 127 drug licenses and registering 17 First Information Reports.

The seizures targeted pharmaceutical substances, such as tramadol and tapentadol, which have potential for misuse. The discovery of these drugs stored in unlicensed godowns without sales records indicates significant regulatory gaps in the local supply chain. The resulting legal proceedings and license cancellations impact the operational stability of pharmaceutical businesses in the region.